Tag Archives: ALXN

Alexion’s $8.4 Billion Synageva Buyout Spooks Street

Big-cap biotech Alexion Pharmaceuticals on Wednesday agreed to pay $8.4 billion in cash and stock for fellow rare-disease specialist Synageva BioPharma, a price that investors greeted with trepidation. Alexion’s stock fell 8% to close at 155.01, while Synageva’s soared 112% to 203.39. Alexion (ALXN) agreed to pay $115 in cash and 0.6581 Alexion share for every Synageva (GEVA) share, which at Alexion’s nine-day volume-weighted average closing price

Alexion Buying Synageva For $230 A Share; Stock Slips

Big-cap biotech Alexion Pharmaceuticals (ALXN) agreed to pay $8.4 billion in cash and stock for fellow rare-disease specialist Synageva BioPharma (GEVA) Wednesday, which at $230 a share was more than twice Synageva’s closing price. Alexion stock dipped and Synageva soared in early trading. Alexion agreed to pay $115 in cash and 0.6581 Alexion share for every Synageva share, in a bid to diversify from its sole marketed product, Soliris. Alexion is

Forget Google: 5 Top Stocks With Earnings Thursday

Tech titan Google (GOOGL) will make headlines with its quarterly earnings after the close on Thursday. But Google’s growth is sluggish and the stock is lackluster. Check out these five stocks with better performance than the search giant, including drugmaker AbbVie (ABBV) and coffee giant Starbucks (SBUX). Alexion, AbbVie Drug Earnings Alexion Pharmaceuticals (ALXN) is projected to see earnings decline by 13% to $1.33 a share when it reports its